Fundraising Fox
/Companies
Sign in

Moichor

YC W21

San Francisco, US · Founded 2019 · Delaware corporation · 29 employees · 5 known investors

Find your way into Moichor

Each arrow is one introduction. Sign up to fill in the first one.

135 people can intro you to Liam

Ask Rebecca Mitchem to introduce you to Liam Cattell

You →Rebecca · together at Moichor →Liam

Sign up to find every way you can get introduced to Moichor

  • Your email: who you already know at Moichor, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Moichor team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Moichor is an animal diagnostics laboratory providing automated blood count and cytology testing for veterinarians across the United States. The company uses artificial intelligence and computer vision to deliver species-specific pathology results through both send-in laboratory services and an in-clinic hematology device.

AI & Machine LearningHealthtechMedical DevicesDiagnosticsUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (W21)

Moichor was founded in 2019 by Shevy Karbasi, Thanh Le, Matt Chen, Joe Faiella, and Sherveen Karbasiafshar.

SKShevy Karbasi
Shevy KarbasiFounderGeneral Partner at NPU Ventures
TLThanh Le
Thanh LeCo-Founder | Chief Technology Officer2018–2025
MCMatt Chen
Matt ChenCo-founderGeneral Partner at NPU Ventures
JF
Joe FaiellaCEO
SK
Sherveen KarbasiafsharCo-founder
DKDr. Kaori Davis
Dr. Kaori DavisChief Medical Officer
LCLiam Cattell
Liam CattellCTOLiam Cattell holds a Ph.D. in Biomedical Engineering from the University of Oxford and has research experience in computer vision, image processing, and machine learning. He is CTO of Moichor, which provides automated blood count and cytology testing for veterinarians using artificial intelligence and computer vision technology.
MC
Matthew ChenFounderGeneral Partner at NPU Ventures
DR
Dr. Rand J. WilsonDirector of Clinical Pathology

Board

AS
Alex SalazarBoard director

Investors · 5

Parade Ventureslisted by Parade VenturesSan Francisco · $1M

How we know: the VCSheet dataset · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

Cory Levyreported

How we know: Y Combinator's founder network · Not right? Tell us

Flight VenturesreportedSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$11.3M disclosed across 2 rounds · 2021–2022

▶$6.2MraisedFeb 2023 · 10 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Sherveen KarbasiafsharExecutive Officer, Director
  • Alex SalazarDirector
  • Matthew ChenExecutive Officer, Director
Offering amount
$6.2M
Amount sold
$6.2M
First sale
Dec 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedMay 2021 · 11 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Sherveen KarbasiafsharExecutive Officer, Director
  • Matthew ChenExecutive Officer, Director
  • Alex SalazarDirector
Offering amount
$5M
Amount sold
$5M
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 7

FidoCureOne Health operates a clinical trial platform using canine cancer data to accelerate and de-risk human oncology drug development. The company leverages a dataset of 2 billion datapoints from dogs with naturally occurring cancer to serve as a comparative model for pharmaceutical R&D, helping drug developers validate efficacy and identify biomarkers before human trials.
BiocartesianBiocartesian provides optical pooled screening services for functional genomics research. The company uses its proprietary ARADIA technology to link microscopy-based cellular phenotypes with genetic perturbations, enabling researchers to conduct large-scale CRISPR screens and other genomic studies with visual, spatial, and live-cell readouts.
VcahospitalsVCA Animal Hospitals operates a national network of veterinary hospitals providing primary care, specialty care, emergency care, urgent care, and boarding services for pets. The company combines advanced medical technology and procedures with compassionate care for pet owners and their animals.
AminoAnalyticaAmino Analytica designs rapid molecular diagnostic tests for emerging infectious diseases and biological threats, developed in weeks rather than the traditional 12+ months. The company combines point-of-care diagnostics technology with AI-driven bionanotechnology to enable earlier detection and faster pandemic response.
NumenNumen develops at-home cancer diagnostics and health data collection infrastructure using machine learning models to enable earlier intervention and improve patient outcomes.
Small DoorSmall Door provides veterinary care for pets through modern clinics that combine technology with personalized service. The company serves pet owners seeking convenient, transparent, and integrative veterinary care.
WagwalkingWag! is a marketplace that connects pet owners with local pet caregivers for services including dog walking, drop-in visits, pet sitting, and boarding. The platform vets caregivers through background checks and provides real-time updates and communication tools for pet owners to monitor their pets during service.

Companies working in the same space as Moichor.

In the news

Moichor raises $4m to disrupt animal blood testingprnewswire.com · Apr 2021Moichor Funding | $2.5-3.5M Revenue | Complete Analysis | Extruct AIextruct.ai · Mar 2021

Frequently asked questions

What does Moichor do?
Moichor is an animal diagnostics laboratory providing automated blood count and cytology testing for veterinarians across the United States. The company uses artificial intelligence and computer vision to deliver species-specific pathology results through both send-in laboratory services and an in-clinic hematology device.
Who founded Moichor?
Moichor was founded by Shevy Karbasi, Thanh Le, Matt Chen, Joe Faiella, Sherveen Karbasiafshar in 2019.
Who are Moichor's investors?
Moichor's investors include Neotribe Ventures, Parade Ventures, Y Combinator, Cory Levy, Flight Ventures.
How much funding has Moichor raised?
Moichor has disclosed $11.3M raised across 2 rounds.
Where is Moichor headquartered?
Moichor is headquartered in San Francisco, US.